Get all your news in one place.
100's of premium titles.
One app.
Start reading
Inverse
Inverse
Science
Mark R. O'Brian, and ,The Conversation

New mRNA cancer vaccine has a key difference from most jabs


Media outlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.